Details of the Drug Reposition

General Information of This Drug (ID: DM471KJ)

Drug Name
Omeprazole   DM471KJ
Synonyms Losec (TN)
Therapeutic Class
Antiulcer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
7 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Peptic esophagitis DISJSGBZ N.A. Approved [1]
Laryngeal disorder DISDKUQO N.A. Approved [1]
Gastrinoma DIS4IMNF 2C10.1 Approved [1]
Cystic fibrosis DIS2OK1Q CA25 Approved [1]
Gastric ulcer DISBBGVO DA60 Approved [1]
Peptic ulcer DISL8XZI DA61 Approved [1]
Nausea DIS50TOO MD90 Approved [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Indications(s)
4 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastroesophageal reflux disease DISQ8G5S DA22.Z Discontinued in Phase 2 [2]
Erosive esophagitis DIST4BF8 DA25.0 Discontinued in Phase 2 [3]
Duodenal ulcer DISNHHCN DA63 Discontinued in Phase 2 [4]
Dyspepsia DISYEEY6 MD92 Discontinued in Phase 2 [5]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Congenital laryngomalacia DISWQG9L N.A. Investigative [1]
------------------------------------------------------------------------------------

References

1 Omeprazole FDA Label
2 Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
3 ClinicalTrials.gov (NCT01020305) Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
4 Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma
5 ClinicalTrials.gov (NCT01652014) Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies